FDA product code DLT: Hemagglutination, Opiates

DLT is the FDA product code for hemagglutination, opiates. It is a Class II device, regulated under 21 CFR 862.3650 and reviewed by the Clinical Toxicology panel. FDA has cleared 1 510(k) submission under DLT. The average 510(k) review took 109 days (median 109).

Classification

FieldValue
Device nameHemagglutination, Opiates
Device classClass II
Regulation21 CFR 862.3650
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Top DLT applicants

ApplicantClearancesLatest
Syva Co.11979-06-15

Most recent DLT clearances

510(k)ApplicantDeviceDecision dateReview days
K790400Syva Co.URINE NEGATIVE CALIBRATOR1979-06-15109

Recalls for DLT devices

openFDA lists no recalls for product code DLT.

Frequently asked questions

What is FDA product code DLT?

DLT is the FDA product code for hemagglutination, opiates. It is a Class II device, regulated under 21 CFR 862.3650 and reviewed by the Clinical Toxicology panel.

What device class is DLT?

Class II, regulation 21 CFR 862.3650. Typical premarket route: 510(k).

How long does a 510(k) take for product code DLT?

Across 1 cleared submissions the average was 109 days from receipt to decision (median 109).

Which companies have the most DLT clearances?

Syva Co. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup